114 companies

CSPC Pharmaceutical Group

Market Cap: HK$120.2b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

1093

HK$10.51

7D

-4.1%

1Y

122.7%

Sihuan Pharmaceutical Holdings Group

Market Cap: HK$13.1b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.

460

HK$1.44

7D

0.7%

1Y

171.7%

China Shineway Pharmaceutical Group

Market Cap: HK$6.3b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

2877

HK$8.32

7D

0.6%

1Y

3.1%

Jacobson Pharma

Market Cap: HK$3.0b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

2633

HK$1.49

7D

2.8%

1Y

156.9%

Ab&B Bio-Tech JS

Market Cap: HK$20.3b

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.

2627

HK$51.50

7D

9.2%

1Y

n/a

3SBio

Market Cap: HK$74.3b

An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.

1530

HK$31.08

7D

-7.3%

1Y

442.4%

JBM (Healthcare)

Market Cap: HK$2.5b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

2161

HK$3.04

7D

4.8%

1Y

226.9%

Innovent Biologics

Market Cap: HK$170.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

1801

HK$99.45

7D

2.0%

1Y

128.9%

Sino Biopharmaceutical

Market Cap: HK$146.1b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

1177

HK$8.17

7D

4.5%

1Y

160.2%

Brii Biosciences

Market Cap: HK$1.4b

Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.

2137

HK$2.00

7D

-6.1%

1Y

108.3%

Guangzhou Innogen Pharmaceutical Group

Market Cap: HK$24.2b

Engages in development of drugs.

2591

HK$53.00

7D

-7.4%

1Y

n/a

WuXi Biologics (Cayman)

Market Cap: HK$134.0b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

2269

HK$32.92

7D

6.4%

1Y

220.9%

Akeso

Market Cap: HK$158.8b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

9926

HK$176.90

7D

6.9%

1Y

285.4%

Uni-Bio Science Group

Market Cap: HK$955.4m

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.

690

HK$0.16

7D

10.3%

1Y

201.9%

Grand Pharmaceutical Group

Market Cap: HK$34.0b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

512

HK$9.70

7D

15.6%

1Y

131.0%

WuXi XDC Cayman

Market Cap: HK$69.5b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$57.70

7D

-7.3%

1Y

204.0%

TYK Medicines

Market Cap: HK$6.0b

A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.

2410

HK$15.73

7D

-23.0%

1Y

-27.2%

Qyuns Therapeutics

Market Cap: HK$6.0b

A clinical-stage biotech company, focuses on the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.

2509

HK$27.18

7D

21.0%

1Y

14.4%

Extrawell Pharmaceutical Holdings

Market Cap: HK$301.1m

An investment holding company, develops, manufactures, and sell of pharmaceutical products in the People’s Republic of China and Hong Kong.

858

HK$0.13

7D

-2.3%

1Y

231.6%

Mabpharm

Market Cap: HK$3.3b

A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.

2181

HK$0.81

7D

9.5%

1Y

121.9%

Beijing Luzhu Biotechnology

Market Cap: HK$5.0b

A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China.

2480

HK$24.98

7D

6.3%

1Y

9.3%

Lee's Pharmaceutical Holdings

Market Cap: HK$1.1b

An investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally.

950

HK$1.85

7D

-14.0%

1Y

50.4%

BioDlink International

Market Cap: HK$1.8b

An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.

1875

HK$2.30

7D

-2.5%

1Y

24.3%

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$10.0b

A biotechnology company, engages in the research and development of novel antibody-based drugs in the People’s Republic of China, the United States, and internationally.

2315

HK$25.00

7D

1.5%

1Y

284.6%

Fusen Pharmaceutical

Market Cap: HK$255.1m

An investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China.

1652

HK$0.34

7D

-2.8%

1Y

-64.1%

HBM Holdings

Market Cap: HK$9.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

2142

HK$12.44

7D

2.1%

1Y

1,020.7%

Ocumension Therapeutics

Market Cap: HK$9.2b

Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.

1477

HK$11.32

7D

3.7%

1Y

111.6%

Genor Biopharma Holdings

Market Cap: HK$2.4b

A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.

6998

HK$4.65

7D

24.7%

1Y

244.4%

Ascentage Pharma Group International

Market Cap: HK$33.7b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

6855

HK$90.65

7D

5.3%

1Y

215.9%

CARsgen Therapeutics Holdings

Market Cap: HK$11.7b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

2171

HK$21.06

7D

-7.2%

1Y

469.2%

Hua Medicine (Shanghai)

Market Cap: HK$3.4b

Engages in the development and commercialization of drugs for the treatment of diabetes in China.

2552

HK$3.47

7D

-0.6%

1Y

201.7%

XtalPi Holdings

Market Cap: HK$40.9b

An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.

2228

HK$10.17

7D

9.9%

1Y

57.7%

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$106.6b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

6990

HK$466.60

7D

7.5%

1Y

184.3%

Transcenta Holding

Market Cap: HK$1.6b

A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.

6628

HK$3.94

7D

15.9%

1Y

185.5%

Shanghai Junshi Biosciences

Market Cap: HK$47.2b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

1877

HK$34.22

7D

6.9%

1Y

190.0%

Medtide

Market Cap: HK$5.8b

A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.

3880

HK$40.64

7D

13.0%

1Y

n/a

Page 1 of 4